Market Cap 0.00
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 44.24
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 79,900
Avg Vol 267,114
Day's Range N/A - N/A
Shares Out 0.00
Stochastic %K 67%
Beta N/A
Analysts Strong Sell
Price Target $46.00

Company Profile

Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in ther...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 41 58 455 85 92
Address:
Zählerweg 10, Zug, Switzerland
Latest News on GALDY
No data available.